Roche acquires Versant's MS play Inception 5, VC launches another

Roche (SIX:ROG; OTCQX:RHHBY) is exercising its option to acquire Versant Venture’s remyelination play Inception 5 Inc. Concurrently, the VC is doubling down on regenerative therapies for neurology through the launch of successor company Pipeline Therapeutics Inc., which has ambitions in

Read the full 404 word article

User Sign In